MCBR has a provision to facilitate Biopharma companies with GMP lab/infra-structure to start MAHE-Pvt. Partnership research unit at MAHE at a very nominal usage fee or potential option to outsource translational research projects to MCBR.
MCBR is at Advanced stage of collaborative discussions with
• Stempeutics Research
• Curio Biotech, Switzerland
• Esco Aster, Singapore
• Cipla Ltd
We welcome more collaborative initiative to the companies for developing novel Biotherapeutics products.